Clarification of protein precipitate suspensions using anionic polymeric flocculants
View Patent ↗Protein suspensions comprising soluble and insoluble components are purified via flocculation with anionic polymers, such as polyacrylamides, potato starch, or modified cellulose. The procedure improves the efficiency of solid/liquid separations and can minimize or eliminate the requirement for centrifugation and/or filtration in large scale biotechnological processes. The method is particularly well suited for the purification and clarification of protein suspensions containing soluble somatotropin monomer using polyacrylamide and polysaccharide flocculants.
1. An aqueous somatotropin (ST) protein suspension comprising somatotropin monomers, somatotropin oligomers, and an anionic polymer having a polymer charge density of between about 1% and 30%;
wherein the ST monomers are soluble, wherein the ST oligomers are precipitated, and wherein the anionic polymer and the oligomers are aggregated.
2. The ST protein suspension of claim 1 , wherein the anionic polymer is a polyacrylamide.
3. The ST protein suspension of claim 2 , wherein the polyacrylamide has a polymer charge density between about 5% and about 12%.
4. The ST protein suspension of claim 2 , wherein the polyacrylamide has a polymer charge density between about 8% and about 11%.
5. An aqueous somatotropin (ST) protein suspension comprising ST monomers, ST oligomers, and an anionic polymer;
wherein the ST monomers are soluble, wherein the ST oligomers are precipitated wherein the anionic polymer and the precipitated oligomers are aggregated, and wherein the anionic polymer is a polysaccharide.
6. The ST protein suspension of claim 5 , wherein the anionic polymer is starch or modified cellulose.
7. The ST protein suspension of claim 5 , wherein the polysaccharide is potato starch.
8. The ST protein suspension of claim 1 , wherein the anionic polymer is present in the suspension at a concentration between about 1 and about 1000 ppm.
9. The ST protein suspension of claim 1 , wherein the anionic polymer is present in the suspension at a concentration between about 10 and about 100 ppm.
10. The ST protein suspension of claim 1 , wherein the anionic polymer is present in the suspension at a concentration between about 20 and about 30 ppm.
11. The ST protein suspension of claim 1 , wherein the anionic polymer's average molecular weight is greater than about 100,000.
12. The ST protein suspension of claim 1 , wherein the anionic polymer's average molecular weight is greater than about 1,000,000.
13. The ST protein suspension of claim 1 , wherein the anionic polymer's average molecular weight is greater than about 10,000,000.
14. The ST protein suspension of claim 1 , wherein the anionic polymer has a polymer charge density between about 5% and about 12% and an average molecular weight greater than about 10,000,000.
15. The ST protein suspension of claim 1 , wherein the somatotropin is bovine somatotropin.
16. The ST protein suspension of claim 1 , wherein the anionic polymer is a polyacrylamide present in an amount from about 1 to about 100 ppm having a polymer charge density from about 5% to about 12% and an average molecular weight greater than about 1,000,000.
17. The ST protein suspension of claim 1 , wherein the pH of the protein suspension is about 4.5, and the anionic polymer is a polyacrylamide present in an amount of about 25 ppm, having a charge density of about 10%, and an average molecular weight of about 16,000,000.
18. The ST protein suspension of claim 5 , wherein the anionic polymer is present in the suspension at a concentration between about 10 and about 100 ppm.
19. The ST protein suspension of claim 5 , wherein the anionic polymer's average molecular weight is greater than about 100,000.
20. The ST protein suspension of claim 5 , wherein the anionic polymer's average molecular weight is greater than about 1,000,000.